Kelly Wang
Background and experience
As head of ZS’s strategy and transformation practice in Asia-Pacific, Kelly partners with pharma and medtech clients to solve complex business challenges and deliver meaningful, lasting change.
Since 2010, Kelly has been a go-to-market expert and trusted adviser in commercialization and transformation across a broad range of therapeutic areas and consumer health categories. She navigates the complexities of healthcare regulations in China and the Asia-Pacific region, supporting clients in transformative initiatives that drive patient-centric capabilities and personalized experiences for improved outcomes. Kelly’s strategic approach—blending vision, experience and leadership—empowers her to consistently deliver results for clients in the dynamic healthcare landscape.
Prior to ZS, Kelly worked with a global top leadership advisory firm and led innovative technology launches at Abbott Laboratories as commercialization director of greater China. Kelly started her career at the DuPont Global Marketing Leadership Development Program.
Education
MBA, Duke University
Bachelor of Arts in international trade, East China University